Immunotherapy has dramatically changed the therapeutic landscape of oncology, and has
become standard of care in multiple cancer types in front or late lines of therapy, with some …

Immunotherapy has revolutionized cancer treatment over the past decade. As it is
increasingly introduced into routine clinical practice, immune-related complications have …

Background We report a case of neuromyelitis optica spectrum disorders (NMOSD), who
developed after the pembrolizumab treatment, an immune checkpoint inhibitor, against lung …

Abstract Purpose of Review Immune checkpoint inhibitor (ICI) use has been on the rise for
treatment of many different malignancies. Subsequently, more has been learned about …

Immune checkpoint inhibitors (ICIs) are cancer immunotherapies that enhance the body's
own immune system to treat cancer. ICI treatment, however, can cause immune-related …

Immune checkpoint inhibitor monoclonal antibodies allow the host's immune system to
attack tumors, which has revolutionized cancer care over the last decade. As the use of …

We report a rare case of paraneoplastic neurological syndrome with dual seropositivity of
anti‐aquaporin‐4 and myelin oligodendrocyte glycoprotein antibodies in a 40 year‐old …

The review of publications on the safety profiles of three different immunosuppressants and
immunomodulators (Alemtuzumab (ALZ), ipilimumab and nivolumab) published between …

Programmed cell death-1 (PD-1) is one of the important co-inhibitory receptors in
maintaining tolerance and inhibiting the proliferation and activity of activated immune cells …